Article Details

Obesity drugmaker BioAge targets $158 million in IPO | Fortune

Retrieved on: 2024-09-19 11:26:57

Tags for this article:

Click the tags to see associated articles and topics

Obesity drugmaker BioAge targets $158 million in IPO | Fortune. View article details on hiswai:

Excerpt

The company is offering 7.5 million shares for $17 to $19 apiece, according to a filing Wednesday.

Article found on: fortune.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo